Ceramides and mitochondrial fatty acid oxidation in obesity

: Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved...

ver descrição completa

Detalhes bibliográficos
Autores: Fucho Salvador, Raquel, Casals i Farré, Núria, Serra i Cucurull, Dolors, Herrero Rodríguez, Laura
Tipo de documento: artigo
Estado:Versión enviada para evaluación y publicación
Data de publicação:2016
País:España
Recursos:Universidad de Barcelona
Repositório:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/118858
Acesso em linha:https://hdl.handle.net/2445/118858
Access Level:Acceso aberto
Palavra-chave:Obesitat
Carnitina palmitoïl-transferasa 1
Resistència a la insulina
Àcids grassos
Obesity
Carnitine palmitoyltransferase I
Insulin resistance
Fatty acids
Descrição
Resumo:: Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes to lipid accumulation within the cells, conferringmore susceptibility to cell dysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity-derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity.¿Fucho, R., Casals, N., Serra, D., Herrero, L. Ceramides and mitochondrial fatty acid oxidation in obesity. FASEB J. 31, 000-000 (2017). www.fasebj.org